Patricio S. Espinosa: Anticoagulation Is Not an Absolute Contraindication to Amyloid Therapy
Patricio S. Espinosa, Chief of Neurology and Institute Director at Espinosa Neuroscience Institute, shared a post on X:
”MYTH vs FACT: Amyloid Therapies & Anticoagulants
There is a common misconception that patients on anticoagulants (blood thinners) cannot receive amyloid-targeted therapies such as Kisunla (donanemab) and Leqembi (lecanemab).
MYTH:
Patients on anticoagulation are not candidates for amyloid therapies.
FACT:
With careful patient selection, strict adherence to protocols, and close monitoring, patients on anticoagulants can safely receive these therapies.
At Espinosa Neuroscience Institute, we have treated patients on anticoagulation with amyloid-targeted therapies without complications, by following:
- Rigorous MRI screening protocols
- Close monitoring for ARIA (Amyloid-Related Imaging Abnormalities)
- Individualized risk–benefit assessment
- Coordination of care across specialties
The key is not exclusion – it’s precision medicine.
These therapies are transforming how we treat mild cognitive impairment and early Alzheimer’s disease, and we should not deny patients access based on outdated assumptions.
Bottom line:
Anticoagulation is not an absolute contraindication – it requires expert management and protocol-driven care.”

Stay updated with Hemostasis Today.
-
Nov 18, 2026, 01:45Shikha Jha: My Takeaways from the 4th GANSID International Congress
-
Nov 18, 2026, 01:34Zeeshan Ahmed Khattak: Treatment of Fever and Neutropenia in Hematology/Oncology and Hematopoietic Cell Transplant Patients
-
Nov 17, 2026, 23:45Cajetan Reichardt: LAAO vs. OAC in AF – Balancing Nonprocedural Bleeding and Ischemic Stroke Risk
-
Nov 17, 2026, 23:42Brian Tegtmeyer: Expanding Pre-Hospital Administration of Low-Titer O Positive Whole Blood
-
Nov 17, 2026, 23:41Mansi Kala: Advancing Hematology – From Evidence to Clinical Excellence
-
Nov 17, 2026, 23:40Nathan Connell: Registered for the WFH Comprehensive Care Summit 2027 in Prague
-
Nov 17, 2026, 23:38Yaariv Khaykin: Does Reducing AF Burden After Ablation Change the Need for Anticoagulation?
-
Nov 17, 2026, 23:38Amos Gitonga Mbaabu: Strengthening Care and Advocacy for Haemophilia and SCD across Southern Africa
-
Nov 17, 2026, 23:35Muhammad Sameed Altaf: A Decade of Working Together for Thalassemia Awareness and Patient Support